Cargando…
Leveraging Novel Integrated Single-Cell Analyses to Define HIV-1 Latency Reversal
While suppressive antiretroviral therapy can effectively limit HIV-1 replication and evolution, it leaves behind a residual pool of integrated viral genomes that persist in a state of reversible nonproductive infection, referred to as the HIV-1 reservoir. HIV-1 infection models were established to i...
Autores principales: | Zhao, Suhui, Tsibris, Athe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310207/ https://www.ncbi.nlm.nih.gov/pubmed/34206546 http://dx.doi.org/10.3390/v13071197 |
Ejemplares similares
-
Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting
por: Lilie, Tyler, et al.
Publicado: (2023) -
Barriers to a cure for HIV in women
por: Gianella, Sara, et al.
Publicado: (2016) -
HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019) -
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023) -
HIV‐1 proviral landscape characterization varies by pipeline analysis
por: Ferreira, Fernanda A, et al.
Publicado: (2021)